Article

Cost-effectiveness of digital therapeutics for essential hypertension

2022-03-04

Abstract excerpt

<h4>Background</h4> Hypertension increases the risk of cardiovascular and other diseases. Lifestyle modification is a significant component of nonpharmacological treatments for hypertension. We previously reported the clinical efficacy of digital therapeutics (DTx) in the HERB-DH1 trial. However, there is still a lack of cost-effectiveness assessments evaluating the impact of prescription DTx. This study aimed to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 83e2234f-6eee-5389-b90b-15f2b498152b
DOI: 10.1101/2022.03.02.22271583

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of digital therapeutics for essential hypertensionDOI 10.1101/2022.03.02.22271583Read

Cost-effectiveness of Comprehensive screening of general population for hypertension: Can it save money and Life? Systematic review of Pharmacoeconomic StudiesSemantic proximity Read

Cost-effectiveness of alternative cascade screening strategies for familial hypercholesterolemia with realistic cascade screening acceptance rates and use of high-cost drugsSemantic proximity Read

Determining Cost-Saving Risk Thresholds for Statin UseSemantic proximity Read

Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): Protocol for a primary care based, open-label, randomised controlled non-inferiority trialSemantic proximity Read

Preferences for genetic interventions for SCA and Huntington’s disease: results of a discrete choice experiment among patients.Semantic proximity Read

Pharmacoepidemiology simulation study practices: A methodological reviewSemantic proximity Read

Effectiveness and Cost-effectiveness of General Health Checks in Adults: A Systematic ReviewSemantic proximity Read

Could Chinese cardiovascular chronic conditions patients gain benefits from pharmaceutical services? A multilevel meta-analysisSemantic proximity Read

A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraineSemantic proximity Read

Cost savings from managing hypertension in primary health care clinics in KuwaitSemantic proximity Read

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial.Semantic proximity Read

Cost-Utility Analysis of Pitavastatin in Dyslipidemia: Vietnam CaseSemantic proximity Read